Members

Johnson & Johnson Innovative Medicine is leading where medicine is going.

Junipr Research provides clinical strategy and operations services, accelerating time to market through patient-centered study designs and high-quality data for Biotech and MedTech.

Eurogentec, a Kaneka Corporation company, provides custom and catalog solutions for research, diagnostics, and therapeutics, serving biotech and pharmaceutical industries with GMP-certified, high-quality manufacturing worldwide.

Kedroz Srl is developing the first European multi-pathological digital social network: Stent.care.

KiOmed Pharma offers a unique pipeline of medical devices to tackle invalidating OsteoArthritis, Skin Aging and Eye Disorders & Diseases.

LaCAR Company is a leading innovator in biotechnology, specialising in the development of precise genetic tests for human diagnostics.

Levacells, based in Belgium, designs custom cell culture media and feed supplements using AI and metabolic modeling to optimize cell growth, yield, and quality attributes.

LiveDrop develops instruments for cellular analysis in biotechnologies. Application areas ranging from fundamental research in immunology-oncology to the discovery of therapeutic antibodies and cell therapy.

Lonza Verviers produces and distributes cell culture media and buffers (powder and liquid) for cell therapy and protein production, specializing in custom media (FFM).

UCLouvain's hub for medical device+human research and innovation.

Meurice R&D, founded in 1994, partners with Belgian and international companies in chemistry, biochemistry, brewing, fermentation, food technology, bioprocesses, and protein purification.

Minoryx Therapeutics is a private VC-backed company developing innovative therapies for the treatment of orphan CNS (central nervous system) diseases.

Multitel is a research and innovation centre that offers services to companies and develops new technological concepts in the following fields:

NARILIS advances life sciences research to improve health by studying diseases, diagnosis, treatment, and prevention across all biological levels.

Natix brings together a group of companies with a common vision

neuroClues develops an eye-tracking solution for early detection of neurological diseases by analyzing eye movements to identify specific biomarkers

Neuvasq develops therapeutics to restore neurovascular function, including NVQ042 for vascular retinopathies and NVQ061 to target neurodegenerative diseases like Alzheimer’s, Parkinson’s, multiple sclerosis, and epilepsy.

Novadip develops regenerative therapies for critical bone defects, utilizing adipose-derived stem cells to accelerate healing in conditions like bone non-union and spinal fusion.

Nucleis, a University of Liège spin-off, manufactures and distributes PET radiopharmaceuticals for diagnostics and therapy monitoring, supporting innovative therapies.

Nyxoah develops medical technology for obstructive sleep apnea, focusing on the Genio® system, a hypoglossal nerve stimulation therapy for treating moderate to severe cases.

Oncodesign Precision Medicine is a biopharmaceutical company specializing in precision medicine to treat resistant and metastatic cancers.

OncoDNA is a theranostic and genomic company specialising in precision oncology.